From left ventricular dysfunction to heart failure

Archives des Maladies du Coeur et des Vaisseaux

Volumn 89, Issue 11, 1996, Pages 1397-1402

  Cleland, J G F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

ACL inhibitors; beta blockers; heart failure; progression; ventricular dysfunction

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; RAMIPRIL; THIAZIDE DIURETIC AGENT; TRANDOLAPRIL; WARFARIN;

CORONARY ARTERY DISEASE; HEART DISEASE; HEART FAILURE; HEART VENTRICLE REMODELING; HUMAN; PROGNOSIS; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICOAGULANTS; ATRIAL FIBRILLATION; CARDIOTONIC AGENTS; DEATH, SUDDEN, CARDIAC; DIURETICS; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0029803420     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. McMurray JJV, Cleland JGF. Heart failure in clinical practice. In : McMurray JJV, Cleland JGF (eds). London, Martin Dunitz, 1996.
2. McDonagh TA, Morrison CE, McMurray JJV et al. Global left ventricular systolic dysfunction in North Glasgow (abstract). J Am Coll Cardiol 1996 ; 27 (suppl A) : A 106.
3. Dutka DP, Olivotto I, Ward S et al. Plasma neuro-endocrine activity in very elderley subjects and patients with and without heart failure. Eur Heart J 1995 ; 16 : 1223-30.
4. Cleland JGF, Puri S. How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart Failure : remodeling, resetting, or sudden death ? Br Heart J 1994 ; 72 : S 81-S 86.
5. Cleland JGF. ACE inhibitors for myocardial infarction : how should they be used ? Eur Heart J 1995 ; 16 : 153-9.
6. Nicod P, Gilpin E, Dittrich H et al. Influence on prognosis and morbidity or left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarction. Am J Cardiol 1988 ; 61 : 1165-71.
7. Cleland JGF. The clinical course of heart failure and its modification by ACE inhibitors : insights from recent clinical trials. Eur Heart J 1994 ; 15 : 125-30.
8. Cleland JGF, McMurray JJV, Ray SG. Prevention strategies after myocardial infarction. In : Cleland JGF (ed). London : Science Press, 1994.
9. Rutherford JD, Pfeffer MA, Moye LA et al. Effects of captopril on ischemic events after myocardial infarction : results of the survival and ventricular enlargement trial. Circulation 1994 ; 90 : 1731-8.
10. Cleland JGF, Erhardt L, Hall A, Ball SG. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure : a report from the AIRE study investigators. Eur Heart J 1997 (in press)
11. Cleland JGF, Cowburn PJ, Folk RH. Should all patients with atrial fibrillation receive warfarin ? Eur Heart J 1996 ; 17 674-81.
12. Narang R, Cleland JGF, Ball S et al. Mode of death in chronic heart failure : a request for more accurate classification. Eur Heart J 1996 ; 17 : 1390-1403.
13. Yusuf S. Effect of enalopril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991 ; 325 : 293-302.
14. Cleland JGF, Morgan K. Inhibition of the renin-angiotensin- aldosterone system in heart failure : new insights from basic and clinical research. Curr Opin Cardiol 1996 ; 11 : 252-62.
15. Cleland JGF, McMurray J. From hypertension to heart failure. In : anonymous. London : Science Press, 1995.
16. Sharpe N, Murphy J, Smith H, Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarctions. Lancet 1988 ; i : 255-9.
17. Packer M, Gheorghiade M, Young JB et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med 1993 ; 329 : 1-7.
18. Krum H, Sackner Bernstein JD, Goldsmith RL et al. Double- blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 1995 ; 92 : 1499-506.
19. Cleland JGF, Bristow MR, Erdmann E, Remme WJ, Swedberg K, Waagstein F. Beta-blocking agents in heart failure : should they be used and how ? Eur Heart J 1996 (in press).
20. Cleland JGF, Bulpitt CJ, Falk RH et al. Is aspirin safe for patients with heart failure ? Br Heart J 1995 ; 74 : 215-9.